Stay updated on Immunotherapy for Bladder Cancer Patients Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy for Bladder Cancer Patients Clinical Trial page.

Latest updates to the Immunotherapy for Bladder Cancer Patients Clinical Trial page
- Check4 days agoChange DetectedFooter revision label updated to Revision: v3.3.4 from v3.3.3. This is a minor site version update and does not affect study content or user-facing information.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe study status changed from Recruiting to Active, not recruiting, and several contact details for study personnel were removed.SummaryDifference3%

- Check25 days agoChange DetectedAdded a dedicated Locations section with New Jersey and New York, replacing the previous separate location entries. Updated the page revision to v3.3.3 and removed the HHS Vulnerability Disclosure footer link.SummaryDifference0.3%

- Check54 days agoChange DetectedPublications are now described as automatically filled from PubMed and may not all be about the study. The revision label is updated to v3.3.2, replacing v3.2.0.SummaryDifference0.1%

- Check62 days agoChange DetectedThe government funding lapse notice regarding site operations has been removed from the page.SummaryDifference0.3%

- Check83 days agoChange DetectedNo significant changes detected on the Study Details page for NCT03520491; the content remains focused on trial objectives, design, eligibility criteria, and locations.SummaryDifference0.3%

Stay in the know with updates to Immunotherapy for Bladder Cancer Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy for Bladder Cancer Patients Clinical Trial page.